IDiyas

For the Inventor, By the Inventor

Kyoto, Japan

Muneo Takatani

USPTO Granted Patents = 15

Average Co-Inventor Count = 3.4

ph-index = 6

Forward Citations = 77(Granted Patents)


Company Filing History:

goldMedal15 out of 1,858 
 
Takeda Chemical Industries, Inc.
 patents

Years Active: 1990-2001

Loading Chart...
15 patents (USPTO):Explore Patents
1. 6251905 - Tricyclic compounds, their production and use (2001-06-26),
2. 6235731 - Fused imidazopyridine derivatives as antihyperlipidemic agents (2001-05-22),
3. 5998433 - Condensed compounds, their production and use (1999-12-07),
4. 5958942 - Tricyclic nitrogen ring compounds, their production and use (1999-09-28),
5. 5840732 - Imidazopyridine or imidazopyrimidine compounds, their production and use (1998-11-24),
6. 5767121 - Pyridine derivatives, their production and use (1998-06-16),
7. 5587383 - Imidazopyridine derivatives and their use (1996-12-24),
8. 5561147 - Pyridine derivatives, their production and use (1996-10-01),
9. 5457106 - Pyridine derivatives, their production and use (1995-10-10),
10. 5389658 - Pyridine derivatives, their production and use (1995-02-14),
11. 5246948 - Pyridine derivatives, their production and use (1993-09-21),
12. 5244908 - Imidazopyridine derivatives and their pharmaceutical use (1993-09-14),
13. 4987130 - Substituted amine derivatives, their production and use (1991-01-22),
14. 4981860 - Pyridinium nitrate, composition containing same and their use for (1991-01-01),
15. 4962113 - Pyridinium derivatives, their production and use (1990-10-09),

Title: Muneo Takatani: Innovator in Pharmaceutical Chemistry

Introduction

Muneo Takatani is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 15 patents to his name, Takatani's work has had a substantial impact on the industry.

Latest Patents

Among his latest patents are innovative compounds such as tricyclic compounds and their production methods. One notable patent involves fused imidazopyridine derivatives, which serve as antihyperlipidemic agents. These advancements highlight Takatani's commitment to addressing critical health issues through scientific innovation.

Career Highlights

Muneo Takatani is currently associated with Takeda Chemical Industries, Inc., a leading global pharmaceutical company. His role at Takeda has allowed him to collaborate with other experts in the field and contribute to groundbreaking research and development projects.

Collaborations

Takatani has worked alongside talented colleagues, including Kiminori Tomimatsu and Yumiko Shibouta. Their collaborative efforts have fostered an environment of innovation and creativity, leading to the successful development of new pharmaceutical solutions.

Conclusion

Muneo Takatani's contributions to pharmaceutical chemistry exemplify the importance of innovation in healthcare. His patents and collaborative work continue to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…